A randomized double-blind placebo-controlled clinical trial of nitazoxanide for treatment of mild or moderate COVID-19

EClinicalMedicine (2022) - Comments
pubmed: 35237748 doi: 10.1016/j.eclinm.2022.101310 issn: 2589-5370

Jean-François Rossignol, Matthew C. Bardin, Jessica Fulgencio, Dena Mogelnicki, Christian Bréchot